Page last updated: 2024-11-04

temozolomide and Porokeratosis

temozolomide has been researched along with Porokeratosis in 1 studies

Porokeratosis: A heritable disorder of faulty keratinization characterized by the proliferation of abnormal clones of KERATINOCYTES and lesions showing varying atrophic patches surrounded by an elevated, keratotic border. These keratotic lesions can progress to overt cutaneous neoplasm. Several clinical variants are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis.

Research Excerpts

ExcerptRelevanceReference
"We report a case of temozolomide (TMZ)-induced inflammation of disseminated superficial actinic porokeratosis (DSAP), an uncommon and pre-malignant cutaneous disorder."7.88Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis. ( Gru, AA; Hamann, D; Kaffenberger, BH; Lee, DE, 2018)
"We report a case of temozolomide (TMZ)-induced inflammation of disseminated superficial actinic porokeratosis (DSAP), an uncommon and pre-malignant cutaneous disorder."3.88Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis. ( Gru, AA; Hamann, D; Kaffenberger, BH; Lee, DE, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, DE1
Kaffenberger, BH1
Gru, AA1
Hamann, D1

Other Studies

1 other study available for temozolomide and Porokeratosis

ArticleYear
Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis.
    Dermatology online journal, 2018, Mar-15, Volume: 24, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Biopsy; Dacarbazine; Humans; Inflammation; Male; Middle Aged; Por

2018